Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia

Tenofovir alafenamide (TAF) has similar efficacy compared to tenofovir disoproxil fumarate (TDF), but a less favorable effect on lipids. Aim of this retrospective multicentre study was to evaluate the impact on lipids of switching from rilpivirine (RPV)/ emtricitabine (FTC)/TDF to RPV/FTC/TAF in a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Taramasso, Lucia, Di Biagio, Antonio, Riccardi, Niccolò, Briano, Federica, Di Filippo, Elisa, Comi, Laura, Mora, Sara, Giacomini, Mauro, Gori, Andrea, Maggiolo, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788691/
https://www.ncbi.nlm.nih.gov/pubmed/31603906
http://dx.doi.org/10.1371/journal.pone.0223181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788691/
https://www.ncbi.nlm.nih.gov/pubmed/31603906
http://dx.doi.org/10.1371/journal.pone.0223181

Ejemplares similares